Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash Flows from Operating Activities:
Net income	$ 3,720,103	$ 2,138,663
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	429,718	487,815
Stock compensation expense	473,556	489,748
Bad debt expense	350,000	295,050
(Increase) decrease in:
Accounts receivables	17,001	(2,999,613)
Long-term receivables, prepaid and other assets	(759,122)	764,513
(Decrease) increase in:
Accounts payable	(867,631)	688,073
Accrued liabilities	392,089	(98,821)
Deferred revenue	(271,752)	9,548
Net cash provided by operating activities	3,483,962	1,774,976
Cash Flows from Investing Activities:
Capitalization of software costs	0	(111,241)
Purchase of long-term investments	1,000	0
Purchase of property and equipment	(45,197)	(204,004)
Net cash used in investing activities	(44,197)	(315,245)
Cash Flows from Financing Activities:
Net increase in lines of credit	1,430,000	380,000
Proceeds from issuance of note payable	0	56,078
Redemption of Series B-1 Preferred	0	(999,990)
Proceeds from exercise of warrants	164,997	666,903
Proceeds from employee stock plan	0	244,417
Dividends paid	(293,222)	(488,897)
Payments on notes payable and capital leases	(1,488,610)	(544,088)
Net cash used in financing activities	(186,835)	(685,577)
Net increase in cash and cash equivalents	3,252,930	774,154
Cash and cash equivalents at beginning of period	14,892,439	14,054,006
Cash and cash equivalents at end of period	18,145,369	14,828,160
Supplemental disclosure of cash flow information:
Cash paid for income taxes	143,909	42,630
Cash paid for interest	33,371	146,889
Supplemental disclosure of non-cash investing and financing activities:
Common stock to pay accrued liabilities	436,911	971,127
Preferred stock to pay accrued liabilities	0	200,000
Dividends accrued on preferred stock	$ 439,832	$ 426,737